Ideal Cures chalks out Rs 35 crore capex plan

Ideal Cures chalks out Rs 35 crore capex plan
Mumbai – based tablet coating company Ideal Cures Pvt Ltd (IPCL) is on an expansion spree. The company has charted out a Rs 35 crore capex plan for setting up a new research and development (R&D) facility at Goregoan, in the outskirts of Mumbai as well as for capacity up-gradation at their manufacturing facility at Khambat, Baroda

MakroCare opens Switzerland presence
Life Sciences has always been a top priority for Switzerland. This focus of the country led to good growth of pharmaceutical, biotech, nutrition and medical devices in the country over the decades

Waters releases new hydrophilic interaction chromatography Primer
Waters Corporation released a new 72-page comprehensive guide to hydrophilic interaction chromatography written for experienced separations scientists wishing to broaden their understanding of this invaluable chromatographic technique

TAKE Solutions wins CTX Life Sciences deal
TAKE Solutions entered into a partnership with CTX Life Sciences, a pharmaceutical ingredient and intermediate manufacturing company to provide PharmaReady eCTD – DMF and SPL standard license

‘We will continue to invest in research and technologies’
Sheffield Bio-Sciences is continuously focusing on its commitment to customers. Rizwan Khan, General Manager, Asia-Pacific (APAC) and Latin America (LATAM), Sheffield Bioscience, a Kerry Group Business, reveals the company’s ongoing and upcoming activities to Usha Sharma